Literature DB >> 18822926

Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization.

Nicolino Ruperto1, Alberto Martini.   

Abstract

BACKGROUND: Pediatric rheumatic diseases (PRDs) are rare conditions associated with significant sequelae affecting the quality of life and long-term outcome. The research aimed at studying new therapeutic approaches is difficult because of logistic, methodological and ethical problems. DATA SOURCES: To address these problems, two international networks, the Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Pediatric Rheumatology International Trials Organization (PRINTO) were established. The two networks share the goal to promote, facilitate and conduct high quality research for PRDs.
RESULTS: The PRINTO and PRCSG networks have standardized the evaluation of response to therapy in juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus, and juvenile dermatomyositis, drafted clinical remission criteria in JIA, and provided cross-cultural adapted and validated quality of life instruments including the Childhood Health Assessment Questionnaire and the Child Health Questionnaire into 32 different languages. In this paper we reviewed how the networks of the PRINTO and PRCSG have created the basic premises for the best future assessment of PRDs.
CONCLUSIONS: The PRINTO and PRCSG networks can be regarded as a model for international cooperation or collaboration in other pediatric subspecialties.

Entities:  

Mesh:

Year:  2008        PMID: 18822926     DOI: 10.1007/s12519-008-0034-6

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  43 in total

1.  A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule.

Authors:  J D Connor
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it.

Authors:  N Ruperto; P Garcia-Munitis; L Villa; M Pesce; A Aggarwal; A Fasth; T Avcin; S-C Bae; Z Balogh; C Li; J De Inocencio; M Dibra; P Dolezalova; Y El Miedany; B Flato; M Harjacek; H-I Huppertz; F Kanakoudi-Tsakalidou; N Wulffraat; P Lahdenne; J A Melo-Gomes; D Mihaylova; S Nielsen; I Nikishina; H Ozdogan; K Pagava; V Panaviene; A-M Prieur; A-M Romicka; I Rumba; N Shafaie; G Susic; S Takei; Y Uziel; R Vesely; P Woo; A Martini
Journal:  Ann Rheum Dis       Date:  2005-03-10       Impact factor: 19.103

Review 3.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

4.  Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study.

Authors:  R Gutiérrez-Suárez; A Pistorio; A Cespedes Cruz; X Norambuena; B Flato; I Rumba; M Harjacek; S Nielsen; G Susic; D Mihaylova; C Huemer; J Melo-Gomes; B Andersson-Gare; Z Balogh; C De Cunto; R Vesely; K Pagava; A M Romicka; R Burgos-Vargas; A Martini; N Ruperto
Journal:  Rheumatology (Oxford)       Date:  2006-07-28       Impact factor: 7.580

5.  Preliminary definition of improvement in juvenile arthritis.

Authors:  E H Giannini; N Ruperto; A Ravelli; D J Lovell; D T Felson; A Martini
Journal:  Arthritis Rheum       Date:  1997-07

6.  Standard methodology for Segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. I. Design.

Authors:  E J Brewer; E H Giannini
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

7.  A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

Authors:  Nicolino Ruperto; Kevin J Murray; Valeria Gerloni; Nico Wulffraat; Sheila Knupp Feitosa de Oliveira; Fernanda Falcini; Pavla Dolezalova; Maria Alessio; Ruben Burgos-Vargas; Fabrizia Corona; Richard Vesely; Helen Foster; Joyce Davidson; Francesco Zulian; Line Asplin; Eileen Baildam; Julia Garcia Consuegra; Huri Ozdogan; Rotraud Saurenmann; Rik Joos; Angela Pistorio; Pat Woo; Alberto Martini
Journal:  Arthritis Rheum       Date:  2004-07

Review 8.  International research networks in pediatric rheumatology: the PRINTO perspective.

Authors:  Nicolino Ruperto; Alberto Martini
Journal:  Curr Opin Rheumatol       Date:  2004-09       Impact factor: 5.006

9.  The economic impacts of juvenile rheumatoid arthritis.

Authors:  S H Allaire; B S DeNardo; I S Szer; R F Meenan; J G Schaller
Journal:  J Rheumatol       Date:  1992-06       Impact factor: 4.666

10.  Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.

Authors:  Nicolino Ruperto; Silvia Buratti; Carolina Duarte-Salazar; Angela Pistorio; Andreas Reiff; Bram Bernstein; Maria Rocío Maldonado-Velázquez; Rosalía Beristain-Manterola; Nobuaki Maeno; Syuji Takei; Fernanda Falcini; Loredana Lepore; Charles H Spencer; Polixeni Pratsidou-Gertsi; Alberto Martini; Angelo Ravelli
Journal:  Arthritis Rheum       Date:  2004-06-15
View more
  1 in total

1.  Impact of a telenursing service on satisfaction and health outcomes of children with inflammatory rheumatic diseases and their families: a crossover randomized trial study protocol.

Authors:  Anne-Sylvie Ramelet; Béatrice Fonjallaz; Joachim Rapin; Christophe Gueniat; Michaël Hofer
Journal:  BMC Pediatr       Date:  2014-06-18       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.